1323403-33-3 Usage
General Description
CC220 is a chemical compound that belongs to the class of cyclohexane derivatives. It is a potent antagonist of the CCR1 receptor, which is involved in inflammatory and immune responses. CC220 has been studied for its potential therapeutic use in various autoimmune and inflammatory conditions, such as rheumatoid arthritis and multiple sclerosis. In preclinical studies, CC220 has shown promising results in reducing inflammation and immune system activity. Its mechanism of action involves inhibiting the chemokine receptor, which in turn reduces the recruitment and activation of immune cells at sites of inflammation. Further research and clinical trials are needed to fully understand the therapeutic potential of CC220 in treating inflammatory and autoimmune diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1323403-33-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,2,3,4,0 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1323403-33:
(9*1)+(8*3)+(7*2)+(6*3)+(5*4)+(4*0)+(3*3)+(2*3)+(1*3)=103
103 % 10 = 3
So 1323403-33-3 is a valid CAS Registry Number.
1323403-33-3Relevant articles and documents
METHODS FOR MEASURING SMALL MOLECULE AFFINITY TO CEREBLON
-
, (2018/08/25)
A complex comprises a CRBN having a europium-anti-his antibody on the N-terminus of the CRBN, and a Cy5-conjugated small molecule, wherein the Cy5-conjugated small molecule binds the CRBN, and uses thereof for identifying therapeutic compounds.
3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
-
, (2015/12/11)
Provided herein are methods of using compounds and compositions for treating, managing, and/or preventing systemic lupus erythematosus (SLE). Pharmaceutical compositions and dosing regimens for use in the methods are also provided herein.
SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
-
, (2014/03/21)
Salts and solid forms of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or a stereoisomer thereof, are disclosed. Compositions comprising and methos of using the salts and solid forms are also disclosed.
